Muntner, P. et al. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA 324, 1190–1200 (2020).
Ritchey, M. D. et al. Potential need for expanded pharmacologic treatment and lifestyle modification services under the 2017 ACC/AHA Hypertension Guideline. J. Clin. Hypertens. 20, 1377–1391 (2018).
Strauch, B. et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J. Hypertens. 31, 2455–2461 (2013).
Article CAS PubMed Google Scholar
Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J. & Burnier, M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336, 1114–1117 (2008).
Article PubMed PubMed Central Google Scholar
Jung, O. et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J. Hypertens. 31, 766–774 (2013).
Article CAS PubMed Google Scholar
Brinker, S. et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J. Am. Coll. Cardiol. 63, 834–835 (2014).
Ceral, J. et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens. Res. 34, 87–90 (2011).
Article CAS PubMed Google Scholar
Smithwick, R. H. & Thompson, J. E. Splanchnicectomy for essential hypertension: results in 1,266 cases. J. Am. Med. Assoc. 152, 1501–1504 (1953).
Article CAS PubMed Google Scholar
Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E. & Esler, M. D. Renal sympathetic-nerve ablation for uncontrolled hypertension. N. Engl. J. Med. 361, 932–934 (2009).
Article CAS PubMed Google Scholar
Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275–1281 (2009).
Azizi, M. et al. Patient-level pooled analysis of endovascular ultrasound renal denervation or a sham procedure at 6 months following medication escalation: the RADIANCE Clinical Trial Program. Circulation 149, 747–759 (2023).
Bhatt, D. L. et al. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet 400, 1405–1416 (2022).
Townsend, R. R. et al. Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation. EuroIntervention 16, 89–96 (2020).
Rader, F. et al. Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial. EuroIntervention 18, e677–e685 (2022).
Article PubMed PubMed Central Google Scholar
Zhou, B. et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957–980 (2021).
Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260 (2012).
Article PubMed PubMed Central Google Scholar
Choudhry, N. K. et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension 79, e1–e14 (2022).
Article CAS PubMed Google Scholar
Durand, H. et al. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. J. Hypertens. 35, 2346–2357 (2017).
Article CAS PubMed Google Scholar
Choudhry, N. K., Denberg, T. D., Qaseem, A. & Clinical Guidelines Committee of American College of Physicians. Improving adherence to therapy and clinical outcomes while containing costs: opportunities from the greater use of generic medications: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann. Intern. Med. 164, 41–49 (2016).
Yang, W. et al. Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Curr. Med. Res. Opin. 26, 2065–2076 (2010).
Article CAS PubMed Google Scholar
Fisher, N. D. L. & Mahfoud, F. Medication adherence in hypertension: lessons learned from renal denervation trials. Eur. J. Prev. Cardiol. 30, 34–36 (2023).
Azizi, M. et al. Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial. Circulation 134, 847–857 (2016).
Article CAS PubMed Google Scholar
Azizi, M. et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385, 1957–1965 (2015).
Kandzari, D. E. et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 391, 2346–2355 (2018).
Azizi, M. et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet 397, 2476–2486 (2021).
Article CAS PubMed Google Scholar
DiBona, G. F. & Kopp, U. C. Neural control of renal function. Physiol. Rev. 77, 75–197 (1997).
Article CAS PubMed Google Scholar
Esler, M. et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11, 3–20 (1988).
Article CAS PubMed Google Scholar
Sakakura, K. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J. Am. Coll. Cardiol. 64, 635–643 (2014).
Mahfoud, F., Edelman, E. R. & Bohm, M. Catheter-based renal denervation is no simple matter: lessons to be learned from our anatomy? J. Am. Coll. Cardiol. 64, 644–646 (2014).
Struthoff, H. et al. Histological examination of renal nerve distribution, density, and function in humans. EuroIntervention 19, 612–620 (2023).
Article PubMed PubMed Central Google Scholar
Tzafriri, A. R. Innervation patterns may limit response to endovascular renal denervation. J. Am. Coll. Cardiol. 64, 1079–1087 (2014).
Article PubMed PubMed Central Google Scholar
Mahfoud, F. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J. Am. Coll. Cardiol. 66, 1766–1775 (2015).
Kandzari, D. E. et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. J. Am. Coll. Cardiol. 82, 1809–1823 (2023).
留言 (0)